These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 31603674)
1. Development and Characterization of a Fluorescent Probe for GLS1 and the Application for High-Throughput Screening of Allosteric Inhibitors. Xu X; Kuang Z; Han J; Meng Y; Li L; Luan H; Xu P; Wang J; Luo C; Ding H; Li Z; Bian J J Med Chem; 2019 Nov; 62(21):9642-9657. PubMed ID: 31603674 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles. Xu X; Chang X; Huang J; Zhang D; Wang M; Jing T; Zhuang Y; Kou J; Qiu Z; Wang J; Li Z; Bian J Eur J Med Chem; 2022 Jun; 236():114337. PubMed ID: 35428013 [TBL] [Abstract][Full Text] [Related]
3. Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site. Xu X; Wang J; Wang M; Yuan X; Li L; Zhang C; Huang H; Jing T; Wang C; Tong C; Zhou L; Meng Y; Xu P; Kou J; Qiu Z; Li Z; Bian J J Med Chem; 2021 Apr; 64(8):4588-4611. PubMed ID: 33792311 [TBL] [Abstract][Full Text] [Related]
4. Targeting glutaminase 1 (GLS1) by small molecules for anticancer therapeutics. Chen Y; Tan L; Gao J; Lin C; Wu F; Li Y; Zhang J Eur J Med Chem; 2023 Apr; 252():115306. PubMed ID: 36996714 [TBL] [Abstract][Full Text] [Related]
5. Discovery of novel Glutaminase allosteric inhibitors through drug repurposing and comparative MMGB/PBSA and molecular dynamics simulation. Yousaf R; Navid A; Azam SS Comput Biol Med; 2022 Jul; 146():105669. PubMed ID: 35654625 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors. Jo M; Koizumi K; Suzuki M; Kanayama D; Watanabe Y; Gouda H; Mori H; Mizuguchi M; Obita T; Nabeshima Y; Toyooka N; Okada T Bioorg Med Chem Lett; 2023 May; 87():129266. PubMed ID: 37011768 [TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of a novel glutaminase inhibitor. Cederkvist H; Kolan SS; Wik JA; Sener Z; Skålhegg BS FEBS Open Bio; 2022 Jan; 12(1):163-174. PubMed ID: 34698439 [TBL] [Abstract][Full Text] [Related]
8. Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway. Li B; Cao Y; Meng G; Qian L; Xu T; Yan C; Luo O; Wang S; Wei J; Ding Y; Yu D EBioMedicine; 2019 Jan; 39():239-254. PubMed ID: 30555042 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel glutaminase 1 allosteric inhibitors with an alkane chain tail group. Chang X; Wang M; Zhang D; Zhang Y; Wang J; Li Z; Bian J; Xu X Eur J Med Chem; 2023 Jan; 246():115014. PubMed ID: 36525694 [TBL] [Abstract][Full Text] [Related]
10. Targeting GLS1 to cancer therapy through glutamine metabolism. Yu W; Yang X; Zhang Q; Sun L; Yuan S; Xin Y Clin Transl Oncol; 2021 Nov; 23(11):2253-2268. PubMed ID: 34023970 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue. Song J; Pan C; Li J; Bai R; Zeng Z; Han Y; Chen Z; Hou W; Li Y; Ruan BH ACS Med Chem Lett; 2023 Jan; 14(1):11-17. PubMed ID: 36655131 [TBL] [Abstract][Full Text] [Related]
12. An Economical High-Throughput "FP-Tag" Assay for Screening Glycosyltransferase Inhibitors*. Yin X; Li J; Chen S; Wu Y; She Z; Liu L; Wang Y; Gao Z Chembiochem; 2021 Apr; 22(8):1391-1395. PubMed ID: 33259119 [TBL] [Abstract][Full Text] [Related]
13. Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer. Pan T; Gao L; Wu G; Shen G; Xie S; Wen H; Yang J; Zhou Y; Tu Z; Qian W Biochem Biophys Res Commun; 2015 Jan; 456(1):452-8. PubMed ID: 25482439 [TBL] [Abstract][Full Text] [Related]
15. Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis. Takahashi S; Saegusa J; Sendo S; Okano T; Akashi K; Irino Y; Morinobu A Arthritis Res Ther; 2017 Apr; 19(1):76. PubMed ID: 28399896 [TBL] [Abstract][Full Text] [Related]
16. Glutamine metabolism via glutaminase 1 in autosomal-dominant polycystic kidney disease. Soomro I; Sun Y; Li Z; Diggs L; Hatzivassiliou G; Thomas AG; Rais R; Parker SJ; Slusher BS; Kimmelman AC; Somlo S; Skolnik EY Nephrol Dial Transplant; 2018 Aug; 33(8):1343-1353. PubMed ID: 29420817 [TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Daemen A; Liu B; Song K; Kwong M; Gao M; Hong R; Nannini M; Peterson D; Liederer BM; de la Cruz C; Sangaraju D; Jaochico A; Zhao X; Sandoval W; Hunsaker T; Firestein R; Latham S; Sampath D; Evangelista M; Hatzivassiliou G Cell Metab; 2018 Sep; 28(3):383-399.e9. PubMed ID: 30043751 [TBL] [Abstract][Full Text] [Related]
18. Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization. Xiang L; Mou J; Shao B; Wei Y; Liang H; Takano N; Semenza GL; Xie G Cell Death Dis; 2019 Jan; 10(2):40. PubMed ID: 30674873 [TBL] [Abstract][Full Text] [Related]
19. miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells. Li J; Li X; Wu L; Pei M; Li H; Jiang Y Cell Biol Int; 2019 Aug; 43(8):921-930. PubMed ID: 31115975 [TBL] [Abstract][Full Text] [Related]
20. GLS1 promotes proliferation in hepatocellular carcinoma cells via AKT/GSK3β/CyclinD1 pathway. Xi J; Sun Y; Zhang M; Fa Z; Wan Y; Min Z; Xu H; Xu C; Tang J Exp Cell Res; 2019 Aug; 381(1):1-9. PubMed ID: 31054856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]